We are testing a new treatment called KK8123 in adults with X-linked hypophosphatemia to see if it is safe and how it affects phosphorus levels in the body.
Health conditions and diseases that the clinical trial is designed to study and treat.
X-linked hypophosphatemia (XLH) is a rare genetic disorder that causes low levels of phosphate in the body, leading to weak bones and rickets-like symptoms. It is inherited in an X-linked manner, primarily affecting males and can result in bone pain, deformities, and dental issues.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
